Windlas Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech has informed the stock exchanges that its trading window will be closed from April 1, 2026, until 48 hours after the company's financial results for the year ended March 31, 2026, are made public. This is a standard compliance step under SEBI's Insider Trading Regulations, 2015, and the company's internal code of conduct. During this period, insiders and designated persons are prohibited from trading in the company's shares. The communication was signed by Ananta Narayan Panda, the Company Secretary and Compliance Officer, on March 25, 2026.
This is a routine regulatory filing and does not have a direct impact on the stock price. It signals that the company is preparing to announce its annual (FY26) financial results, which could be a material event for the stock once results are declared.